Summary:
The purpose of this research study is to evaluate the effectiveness and safety of an oral investigational medication that treats moderate to severe plaque psoriasis. The study treatment duration is 52 weeks with approximately 18 office visits.
Qualified Participants Must:
• Have moderate to severe plaque psoriasis
•
Be at least 18 years of age
Qualified Participants May Receive:
Study-related care and investigational study medication.
May receive up to $900 for travel.